Search research articles
Contact Us
Filters
Showing results (211-220 of 228) with videos related to
Page
of 23
Sort By:
Cancer Discovery
|
September 22, 2025
The molecular and functional landscape of resistance to FOLFIRI chemotherapy in metastatic colorectal cancer
Marco Avolio, Simonetta M Leto, Francesco Sassi, et al.
JTO Clinical and Research Reports
|
May 27, 2022
Coronavirus Disease 2019 Outcomes, Patient Vaccination Status, and Cancer-Related Delays During the Omicron Wave: A Brief Report From the TERAVOLT Analysis
Christine M Bestvina, Jennifer G Whisenant, Valter Torri, et al.
ESMO Open
|
August 30, 2017
Radiological imaging markers predicting clinical outcome in patients with metastatic colorectal carcinoma treated with regorafenib: post hoc analysis of the CORRECT phase III trial (RadioCORRECT study)
Riccardo Ricotta, Antonella Verrioli, Silvia Ghezzi, et al.
The Lancet. Haematology
|
May 3, 2016
Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial
Andrés J M Ferreri, Kate Cwynarski, Elisa Pulczynski, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
April 24, 2023
STYLE (NCT03449173): A Phase 2 Trial of Sunitinib in Patients With Type B3 Thymoma or Thymic Carcinoma in Second and Further Lines
Claudia Proto, Sara Manglaviti, Giuseppe Lo Russo, et al.
Oncotarget
|
October 24, 2018
Correction: Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: new lessons for clinical practice from the EVA study
Marina Cazzaniga, Claudio Verusio, Mariangela Ciccarese, et al.
Cancer Discovery
|
November 18, 2021
Fasting-Mimicking Diet Is Safe and Reshapes Metabolism and Antitumor Immunity in Patients with Cancer
Claudio Vernieri, Giovanni Fucà, Francesca Ligorio, et al.
Oncotarget
|
August 31, 2018
Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: new lessons for clinical practice from the EVA study
Marina Cazzaniga, Claudio Verusio, Mariangela Ciccarese, et al.
The Lancet. Haematology
|
October 22, 2017
Whole-brain radiotherapy or autologous stem-cell transplantation as consolidation strategies after high-dose methotrexate-based chemoimmunotherapy in patients with primary CNS lymphoma: results of the second randomisation of the International Extranodal Lymphoma Study Group-32 phase 2 trial
Andrés J M Ferreri, Kate Cwynarski, Elisa Pulczynski, et al.
The Cochrane Database of Systematic Reviews
|
March 3, 2015
Adjuvant chemotherapy for resected early-stage non-small cell lung cancer
Sarah Burdett, Jean Pierre Pignon, Jayne Tierney, et al.
Page
of 23
Search research articles
Search
Showing results (211-220 of 228) with videos related to
Sort By:
Page
of 23
Cancer Discovery
|
September 22, 2025
The molecular and functional landscape of resistance to FOLFIRI chemotherapy in metastatic colorectal cancer
Marco Avolio, Simonetta M Leto, Francesco Sassi, et al.
JTO Clinical and Research Reports
|
May 27, 2022
Coronavirus Disease 2019 Outcomes, Patient Vaccination Status, and Cancer-Related Delays During the Omicron Wave: A Brief Report From the TERAVOLT Analysis
Christine M Bestvina, Jennifer G Whisenant, Valter Torri, et al.
ESMO Open
|
August 30, 2017
Radiological imaging markers predicting clinical outcome in patients with metastatic colorectal carcinoma treated with regorafenib: post hoc analysis of the CORRECT phase III trial (RadioCORRECT study)
Riccardo Ricotta, Antonella Verrioli, Silvia Ghezzi, et al.
The Lancet. Haematology
|
May 3, 2016
Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial
Andrés J M Ferreri, Kate Cwynarski, Elisa Pulczynski, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
April 24, 2023
STYLE (NCT03449173): A Phase 2 Trial of Sunitinib in Patients With Type B3 Thymoma or Thymic Carcinoma in Second and Further Lines
Claudia Proto, Sara Manglaviti, Giuseppe Lo Russo, et al.
Oncotarget
|
October 24, 2018
Correction: Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: new lessons for clinical practice from the EVA study
Marina Cazzaniga, Claudio Verusio, Mariangela Ciccarese, et al.
Cancer Discovery
|
November 18, 2021
Fasting-Mimicking Diet Is Safe and Reshapes Metabolism and Antitumor Immunity in Patients with Cancer
Claudio Vernieri, Giovanni Fucà, Francesca Ligorio, et al.
Oncotarget
|
August 31, 2018
Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: new lessons for clinical practice from the EVA study
Marina Cazzaniga, Claudio Verusio, Mariangela Ciccarese, et al.
The Lancet. Haematology
|
October 22, 2017
Whole-brain radiotherapy or autologous stem-cell transplantation as consolidation strategies after high-dose methotrexate-based chemoimmunotherapy in patients with primary CNS lymphoma: results of the second randomisation of the International Extranodal Lymphoma Study Group-32 phase 2 trial
Andrés J M Ferreri, Kate Cwynarski, Elisa Pulczynski, et al.
The Cochrane Database of Systematic Reviews
|
March 3, 2015
Adjuvant chemotherapy for resected early-stage non-small cell lung cancer
Sarah Burdett, Jean Pierre Pignon, Jayne Tierney, et al.
Page
of 23